- Director - Global Operations
- View Linkedin profile »
Clarity Pharma Research LLC conducts custom research that provides nationally representative, real-world evidence to pharmaceutical and biomedical clients. We specialize in rare diseases and oncology/hematology, and have expertise in other therapeutic areas as well. Our scientists have more than 30 years of experience researching pharmaceutical products, from prelaunch to patent expiration and from orphan drugs to blockbusters. We are focused on custom patient-chart audit/treating physician research in the Americas, Asia and selected other regions. Our methodology can be used to accurately size markets (epidemiology), measure patient share/product share, track uptake, help forecasting, accurately describe practice patterns and the treatment landscape, determine clinical utility, fill in the gaps commonly found in secondary or syndicated data (increasing clients' ROI on those investments), and more. Clarity Pharma provides scientifically valid patient records research that can be generalized to the client's entire target universe, not just to panels or segments of the universe as provided by other suppliers. Results of our research have been accepted by the FDA to modify clinical trial development, our data have aligned with SEER, and articles developed by our scientists and co-investigators have withstood the scrutiny of peer-review medical journals and conferences. We bring clarity to clients’ business decisions.